Loading candles…
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, operates in the pharmaceutical industry. The company manufactures and markets branded pharmaceuticals and health care products, concentrating on specialty formulations across therapeutic areas such as pain management, anti-infectives, and gastroenterology. As of 2025, the company has completed 40 years of operation. Its business model emphasizes teamwork, performance, and agility, and it functions as a debt-free entity.
This page is a live market overview for JENBURKT PHARMACEUTICAL L (JENBURPH) on the NSE. As a listed security, JENBURKT PHARMACEUTICAL L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for JENBURPH before placing trades on tick2trade.
As of the latest feed, JENBURPH last traded at ₹915 on NSE, down ₹0.25 (0.03%) from the previous close of ₹915.25. Today's session range is ₹897.25 – ₹934, against a 52-week band of ₹897.25 – ₹1,073.9. Traded volume today stands at 946 shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for JENBURPH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether JENBURPH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for JENBURKT PHARMACEUTICAL L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in JENBURPH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated JENBURPH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.